Xia Zhongjun
Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
J Pain Res. 2017 Aug 18;10:1943-1952. doi: 10.2147/JPR.S128533. eCollection 2017.
Cancer pain can seriously impact the quality of life (QoL) of patients, and optimal management practices are therefore of paramount importance. The ACHEON survey queried physicians and patients from 10 Asian countries/regions to assess current clinical practices in cancer pain management in Asia. This study presents the data obtained for cancer pain management in mainland China, with an emphasis on practices related to opioid drugs.
In several tertiary hospitals across China, 250 patients experiencing cancer pain and 100 physicians were surveyed on questions designed to assess current cancer pain management practices and cancer pain impact on QoL.
The patient survey showed that 88% of patients reported moderate-to-severe cancer pain, with a median duration of 6 months. The physician survey showed that medical school/residency training with regard to cancer pain management was inadequate in ~80% of physicians. A total of 80% of physicians and 67.2% of patients reported that pain scale was used during pain assessment; 84% of physicians expressed that physician-perceived pain severity was not completely consistent with actual pain the patient experienced. Of the 147 patients who recalled the medication received, 83.7% were administered opioid prescriptions. Of the 240 patients who received treatment, 43.8% perceived the inadequacy of controlling pain. The primary barriers from physicians perceived to optimal pain management included patients' fear of side effects (58%), patients' fear of addiction (53%), patients' reluctance to report pain (43%), physicians' reluctance to prescribe (29%), physicians' inadequacy of pain assessment (27%) and excessive regulation of opioid analgesics (47%).
Knowledge of cancer pain management should be strengthened among physicians. Quantitative pain assessment and principle-based pain management should be combined to achieve pain relief. Misconceptions about opioids in patients and physicians and poor report about pain should be overcome through training/education to improve QoL of patients impacted by pain.
癌症疼痛会严重影响患者的生活质量(QoL),因此最佳管理方法至关重要。ACHEON调查询问了来自10个亚洲国家/地区的医生和患者,以评估亚洲目前癌症疼痛管理的临床实践。本研究展示了在中国内地获得的癌症疼痛管理数据,重点是与阿片类药物相关的实践。
在中国各地的几家三级医院,对250名癌症疼痛患者和100名医生进行了调查,问题旨在评估当前癌症疼痛管理实践以及癌症疼痛对生活质量的影响。
患者调查显示,88%的患者报告有中度至重度癌症疼痛,中位持续时间为6个月。医生调查显示,约80%的医生在癌症疼痛管理方面的医学院校/住院医师培训不足。共有80%的医生和67.2%的患者报告在疼痛评估期间使用了疼痛量表;84%的医生表示医生感知的疼痛严重程度与患者实际经历的疼痛不完全一致。在147名回忆起所接受药物治疗的患者中,83.7%接受了阿片类药物处方。在240名接受治疗的患者中,43.8%认为疼痛控制不足。医生认为实现最佳疼痛管理的主要障碍包括患者对副作用的恐惧(58%)、患者对成瘾的恐惧(53%)、患者不愿报告疼痛(43%)、医生不愿开处方(29%)、医生疼痛评估不足(27%)以及阿片类镇痛药监管过度(47%)。
应加强医生对癌症疼痛管理的了解。应将定量疼痛评估与基于原则的疼痛管理相结合以实现疼痛缓解。应通过培训/教育克服患者和医生对阿片类药物的误解以及疼痛报告不佳的问题,以改善受疼痛影响患者的生活质量。